Ionis board member Frederick Muto retires after 21 years of service

IONIS PHARMACEUTICALS INC

Frederick Muto retired from the Ionis Board of Directors effective July 15, 2022.
Muto served on the Audit, Compensation, Nominating/Governance/Review, and Finance Committees.
He had been a board member for over 21 years, providing exemplary service.
No replacement has been announced; committees will be adjusted accordingly.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Frederick Muto

Member of the Board of Directors

IONS · IONIS PHARMACEUTICALS INC

Effective: 2022-07-15
Filed: July 18, 2022, 7:59 PM ET

On July 15, 2022, Frederick Muto, a member of the Board of Directors (“ Board ”) of Ionis Pharmaceuticals, Inc. (the “ Company ”), notified the Company that he is retiring from the Company’s Board effective July 15, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Frederick Muto retired as Member of the Board of Directors at IONIS PHARMACEUTICALS INC.

Action: retired
Role: Member of the Board of Directors

Exact text from the filing

On July 15, 2022, Frederick Muto, a member of the Board of Directors (“ Board ”) of Ionis Pharmaceuticals, Inc. (the “ Company ”), notified the Company that he is retiring from the Company’s Board effective July 15, 2022.

View on SEC.gov

IONIS PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001140361-22-026165

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.